Regulation of keratin expression by retinoids

Dermato-Endocrinology

Volumn 3, Issue 3, 2011, Pages 136-140

  Törmä, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Epidermis; Keratin; Keratin mutations; Keratinocytes; Retinoic acid; Retinoids

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; CD 336; ETRETIN; INTERMEDIATE FILAMENT PROTEIN; ISOTRETINOIN; KERATIN; RETINOIC ACID; RETINOID DERIVATIVE; RETINOL; TAZAROTENE; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL GROWTH; EPIDERMIS; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; ICHTHYOSIS; NONHUMAN; REVIEW; SKIN APPENDAGE; SKIN IRRITATION;

EID: 80054049205     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.15026     Document Type: Review

References (84)

1. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10:1002-13. (Pubitemid 26285976)
2. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10:940-54. (Pubitemid 26285969)
3. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994; 15:61-79.
4. Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev 1999; 20:689-725. (Pubitemid 30654814)
5. Fisher GJ, Talwar HS, Xiao JH, Datta SC, Reddy AP, Gaub MP, et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 1994; 269:20629-35. (Pubitemid 24260474)
6. Karlsson T, Rollman O, Vahlquist A, Törmä H. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin. Acta Derm Venereol 2004; 84:363-9. (Pubitemid 39312269)
7. Reichrath J, Mittmann M, Kamradt J, Muller SM. Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,- gamma) in normal human skin: an immunohistological evaluation. Histochem J 1997; 29:127-33. (Pubitemid 27192187)
8. Lefebvre P, Martin PJ, Flajollet S, Dedieu S, Billaut X, Lefebvre B. Transcriptional activities of retinoic acid receptors. Vitam Horm 2005; 70:199-264. (Pubitemid 43589019)
9. Minucci S, Horn V, Bhattacharyya N, Russanova V, Ogryzko VV, Gabriele L, et al. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Proc Natl Acad Sci USA 1997; 94:11295-300. (Pubitemid 27450992)
10. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995; 81:541-50.
11. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 1998; 395:199-202. (Pubitemid 28425662)
12. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991; 88:6092-6. (Pubitemid 21914892)
13. Briata P, D'Anna F, Franzi AT, Gherzi R. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding. Exp Cell Res 1993; 204:136-46. (Pubitemid 23203095)
14. Angel P, Szabowski A, Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001; 20:2413-23. (Pubitemid 32531299)
15. Cook SJ, Aziz N, McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol 1999; 19:330-41. (Pubitemid 29018435)
16. Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 1995; 11:2509-14. (Pubitemid 26023818)
17. Deng T, Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 1994; 371:171-5. (Pubitemid 24284018)
18. Andela VB, Rosier RN. The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids. Mol Cancer 2004; 3:8.
19. Rockel JS, Kudirka JC, Guzi AJ, Bernier SM. Regulation of Sox9 activity by crosstalk with nuclear factor kappaB and retinoic acid receptors. Arthritis Res Ther 2008; 10:3.
20. Li Q, Verma IM. NFkappaB regulation in the immune system. Nat Rev Immunol 2002; 2:725-34.
21. Lane EB, McLean WH. Keratins and skin disorders. J Pathol 2004; 204:355-66. (Pubitemid 39468147)
22. Rugg EL, Leigh IM. The keratins and their disorders. Am J Med Genet C Semin Med Genet 2004; 131:4-11. (Pubitemid 39441629)
23. Arin MJ, Mueller FB. Keratins and their associated skin disorders. Eur J Dermatol 2007; 17:123-9. (Pubitemid 46456760)
24. Pekny M, Lane EB. Intermediate filaments and stress. Exp Cell Res 2007; 313:2244-54. (Pubitemid 46850731)
25. Arin MJ. The molecular basis of human keratin disorders. Hum Genet 2009; 125:355-73.
26. Kölsch A, Windoffer R, Leube RE. Actin-dependent dynamics of keratin filament precursors. Cell Motil Cytoskeleton 2009; 66:976-85.
27. Korge B, Stadler R, Mischke D. Effect of retinoids on hyperproliferation-associated keratins K6 and K16 in cultured human keratinocytes: a quantitative analysis. J Invest Dermatol 1990; 95:450-5. (Pubitemid 20331992)
28. Brysk MM, Arany I, Brysk H, Chen SH, Calhoun KH, Tyring SK. Gene expression of markers associated with proliferation and differentiation in human keratinocytes cultured from epidermis and from buccal mucosa. Arch Oral Biol 1995; 40:855-62.
29. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995; 133:501-11.
30. Curto EV, Lambert GW, Davis RL, Wilborn TW, Dooley TP. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun 2002; 291:1052-64. (Pubitemid 34694381)
31. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990; 144:326-32.
32. Poumay Y, Pittelkow MR. Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J Invest Dermatol 1995; 104:271-6.
33. Pol A, Bergers M, van Ruissen F, Pfundt R, Schalkwijk J. A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes. Skin Pharmacol Appl Skin Physiol 2002; 15:252-61.
34. Sugiura K, Muro Y, Futamura K, Matsumoto K, Hashimoto N, Nishizawa Y, et al. The unfolded protein response is activated in differentiating epidermal keratinocytes. J Invest Dermatol 2009; 129:2126-35.
35. Chamcheu JC, Pihl-Lundin I, Mouyobo CE, Gester T, Virtanen M, Moustakas A, et al. Immortalized keratinocytes derived from epidermolytic ichthyosis patients reproduce the disease phenotype: a useful in vitro model for testing new treatments. Br J Dermatol 2011; 164:263-72.
36. Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981; 25:617-25. (Pubitemid 11000143)
37. Gilfix BM, Eckert RL. Coordinate control by vitamin A of keratin gene expression in human keratinocytes. J Biol Chem 1985; 260:14026-9. (Pubitemid 16194606)
38. Lee DD, Stojadinovic O, Krzyzanowska A, Vouthounis C, Blumenberg M, Tomic-Canic M. Retinoidresponsive transcriptional changes in epidermal keratinocytes. J Cell Physiol 2009; 220:427-39.
39. Stellmach V, Leask A, Fuchs E. Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 1991; 88:4582-6. (Pubitemid 21914585)
40. Crowe DL. Retinoic acid mediates post-transcriptional regulation of keratin 19 mRNA levels. J Cell Sci 1993; 106:183-8. (Pubitemid 23286790)
41. Eichner R, Kahn M, Capetola RJ, Gendimenico GJ, Mezick JA. Effects of topical retinoids on cytoskeletal proteins: implications for retinoid effects on epidermal differentiation. J Invest Dermatol 1992; 98:154-61.
42. Rosenthal DS, Griffiths CE, Yuspa SH, Roop DR, Voorhees JJ. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin and keratins 6 and 13 but not keratins 1, 10 and 14. J Invest Dermatol 1992; 98:343-50.
43. Brown LJ, Geesin JC, Rothnagel JA, Roop DR, Gordon JS. Retinoic acid suppression of loricrin expression in reconstituted human skin cultured at the liquidair interface. J Invest Dermatol 1994; 102:886-90. (Pubitemid 24210384)
44. Eichner R, Gendimenico GJ, Kahn M, Mallon JP, Capetola RJ, Mezick JA. Effects of long-term retinoic acid treatment on epidermal differentiation in vivo: specific modifications in the programme of terminal differentiation. Br J Dermatol 1996; 135:687-95. (Pubitemid 26375883)
45. Steijlen PM, Happle R, van Muijen GN, van de Kerkhof PC. Topical treatment with 13-cis-retinoic acid improves Darier's disease and induces the expression of a unique keratin pattern. Dermatologica 1991; 182:178-83.
46. Steijlen PM, Reifenschweiler DO, Ramaekers FC, van Muijen GN, Happle R, Link M, et al. Topical treatment of ichthyoses and Darier's disease with 13-cisretinoic acid. A clinical and immunohistochemical study. Arch Dermatol Res 1993; 285:221-6. (Pubitemid 23210107)
47. Virtanen M, Torma H, Vahlquist A. Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis. J Invest Dermatol 2000; 114:487-93. (Pubitemid 30415334)
48. Tomic-Canic M, Sunjevaric I, Freedberg IM, Blumenberg M. Identification of the retinoic acid and thyroid hormone receptor-responsive element in the human K14 keratin gene. J Invest Dermatol 1992; 99:842-7. (Pubitemid 23002052)
49. Navarro JM, Casatorres J, Jorcano JL. Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 1995; 270:21362-7.
50. Radoja N, Diaz DV, Minars TJ, Freedberg IM, Blumenberg M, Tomic-Canic M. Specific organization of the negative response elements for retinoic acid and thyroid hormone receptors in keratin gene family. J Invest Dermatol 1997; 109:566-72.
51. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2002; 43:1773-808. (Pubitemid 35315797)
52. Lu B, Rothnagel JA, Longley MA, Tsai SY, Roop DR. Differentiation- specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element. J Biol Chem 1994; 269:7443-9. (Pubitemid 24217946)
53. Eckert RL, Welter JF. Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Rep 1996; 23:59-70. (Pubitemid 27015469)
54. Tomic-Canic M, Freedberg IM, Blumenberg M. Codominant regulation of keratin gene expression by cell surface receptors and nuclear receptors. Exp Cell Res 1996; 224:96-102. (Pubitemid 26116892)
55. Jho SH, Vouthounis C, Lee B, Stojadinovic O, Im MJ, Brem H, et al. The book of opposites: the role of the nuclear receptor co-regulators in the suppression of epidermal genes by retinoic acid and thyroid hormone receptors. J Invest Dermatol 2005; 124:1034-43. (Pubitemid 40629106)
56. Kerns M, DePianto D, Yamamoto M, Coulombe PA. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol Biol Cell 2010; 21:4068-75.
57. Ma S, Rao L, Freedberg IM, Blumenberg M. Transcriptional control of K5, K6, K14 and K17 keratin genes by AP-1 and NFkappaB family members. Gene Expr 1997; 6:361-70.
58. Wanner R, Zhang J, Dorbic T, Mischke D, Henz BM, Wittig B, Rosenbach T. The promoter of the HaCaT keratinocyte differentiation-related gene keratin 4 contains a functional AP-2 binding site. Arch Dermatol Res 1997; 289:705-8. (Pubitemid 28014202)
59. Takahashi N, Fujiu Y. Cytokeratins 16 and 10 bind to retinoic acid covalently in skin tissue of mice. Br J Dermatol 2010; 162:974-9.
60. Pavez Lorie E, Chamcheu JC, Vahlquist A, TörmäH. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis. Arch Dermatol Res 2009; 301:475-85.
61. Virtanen M, Sirsjö A, Vahlquist A, Törmä H. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha. Exp Dermatol 2010; 19:674-81.
62. Diaz BV, Lenoir MC, Ladoux A, Frelin C, Demarchez M, Michel S. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem 2000; 275:642-50. (Pubitemid 30039029)
63. Sirsjö A, Gidlöf AC, Olsson A, Törmä H, Ares M, Kleinert H, et al. Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-alpha. Biochem Biophys Res Commun 2000; 270:846-51. (Pubitemid 30444795)
64. Yoshimura K, Uchida G, Okazaki M, Kitano Y, Harii K. Differential expression of heparin-binding EGF-like growth factor (HB-EGF) mRNA in normal human keratinocytes induced by a variety of natural and synthetic retinoids. Exp Dermatol 2003; 12:28-34. (Pubitemid 37526846)
65. Ishida-Yamamoto A, McGrath JA, Chapman SJ, Leigh IM, Lane EB, Eady RA. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol 1991; 97:959-68.
66. Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Lane EB, Eady RA. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99:19-26.
67. Joh GY, Traupe H, Metze D, Nashan D, Huber M, Hohl D, et al. A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 1997; 108:357-61. (Pubitemid 27116238)
68. McLean WH, Morley SM, Higgins C, Bowden PE, White M, Leigh IM, Lane EB. Novel and recurrent mutations in keratin 10 causing bullous congenital ichthyosiform erythroderma. Exp Dermatol 1999; 8:120-3. (Pubitemid 29191364)
69. Kremer H, Lavrijsen AP, McLean WH, Lane EB, Melchers D, Ruiter DJ, et al. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1. J Invest Dermatol 1998; 111:1224-6. (Pubitemid 29115204)
70. Ross R, DiGiovanna JJ, Capaldi L, Argenyi Z, Fleckman P, Robinson-Bostom L. Histopathologic characterization of epidermolytic hyperkeratosis: a systematic review of histology from the National Registry for Ichthyosis and Related Skin Disorders. J Am Acad Dermatol 2008; 59:86-90. (Pubitemid 351832828)
71. Vahlquist A, Gånemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol 2008; 88:4-14. (Pubitemid 351212127)
72. Gatto H, Richard MH, Viac J, Charveron M, Schmitt D. Effects of retinoic acid on interleukin-1 alpha and -1beta expression by normal human keratinocytes cultured in defined medium. Skin Pharmacol 1993; 6:10-9. (Pubitemid 23120910)
73. Humphries JD, Parry EJ, Watson RE, Garrod DR, Griffiths CE. All-trans retinoic acid compromises desmosome expression in human epidermis. Br J Dermatol 1998; 139:577-84. (Pubitemid 28474301)
74. Xiao JH, Feng X, Di W, Peng ZH, Li LA, Chambon P, Voorhees JJ. Identification of heparin-binding EGFlike growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 1999; 18:1539-48. (Pubitemid 29127067)
75. Virtanen M, Gedde-Dahl T Jr, Mork NJ, Leigh I, Bowden PE, Vahlquist A. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001; 81:163-70. (Pubitemid 32800459)
76. Verfaille CJ, Borgers M, van Steensel MA. Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders. J Dtsch Dermatol Ges 2008; 6:355-64. (Pubitemid 351712822)
77. Pavez Loriè E, Cools M, Borgers M, Wouters L, Shroot B, Hagforsen E, et al. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. Br J Dermatol 2009; 160:26-36.
78. Steijlen PM, van Dooren-Greebe RJ, Happle R, Van de Kerkhof PC. Ichthyosis bullosa of Siemens responds well to low-dosage oral retinoids. Br J Dermatol 1991; 125:469-71.
79. Chen S, Ostrowski J, Whiting G, Roalsvig T, Hammer L, Currier SJ, et al. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 1995; 104:779-83.
80. Standeven AM, Teng M, Chandraratna RA. Lack of involvement of retinoic acid receptor alpha in retinoid-induced skin irritation in hairless mice. Toxicol Lett 1997; 92:231-40. (Pubitemid 27400114)
81. Bernard FX, Pedretti N, Rosdy M, Deguercy A. Comparison of gene expression profiles in human keratinocyte mono-layer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis. Exp Dermatol 2002; 11:59-74. (Pubitemid 36934625)
82. Lee DD, Zavadil J, Tomic-Canic M, Blumenberg M. Comprehensive transcriptional profiling of human epidermis, reconstituted epidermal equivalents and cultured keratinocytes using DNA microarray chips. Methods Mol Biol 2010; 585:193-223.
83. Kopan R, Traska G, Fuchs E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J Cell Biol 1987; 105:427-40. (Pubitemid 17101257)
84. Asselineau D, Darmon M. Retinoic acid provokes metaplasia of epithelium formed in vitro by adult human epidermal keratinocytes. Differentiation 1995; 58:297-306.